Globus Medical (GMED) Cash from Financing Activities (2011 - 2026)

Globus Medical's Cash from Financing Activities history runs 16 years deep, the most recent figure standing at $18.2 million for Q1 2026.

• Quarterly Cash from Financing Activities rose 102.86% year-over-year to $18.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$25.6 million (up 95.33% YoY) and the FY2025 annual result came in at -$679.2 million, down 2352.2% from the prior year.
• Cash from Financing Activities was $18.2 million for Q1 2026 at Globus Medical, up from $13.2 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $59.7 million in Q4 2024 and bottomed at -$635.4 million in Q1 2025.
• A 5-year average of -$60.6 million and a median of $2.9 million in 2023 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities soared 1428.54% — and 2024, when it tumbled 4036.09%.
• Globus Medical's Cash from Financing Activities stood at $13.6 million in 2022, then sank by 1845.79% to -$237.3 million in 2023, then jumped by 125.18% to $59.7 million in 2024, then sank by 77.88% to $13.2 million in 2025, then surged by 37.7% to $18.2 million in 2026.
• Business Quant data shows GMED's Cash from Financing Activities at $18.2 million in Q1 2026, $13.2 million in Q4 2025, and -$32.0 million in Q3 2025.